Suppr超能文献

一种小细胞肺癌细胞系产生的免疫抑制因子的鉴定与纯化

Characterization and purification of an immunosuppressive factor produced by a small cell lung cancer cell line.

作者信息

Ikeda T, Masuno T, Ogura T, Watanabe M, Shirasaka T, Hara H, Tanio Y, Kawase I, Kishimoto S

机构信息

Third Department of Internal Medicine, Osaka University Medical School.

出版信息

Jpn J Cancer Res. 1991 Mar;82(3):332-8. doi: 10.1111/j.1349-7006.1991.tb01850.x.

Abstract

The present study was undertaken to determine whether small cell lung cancer (SCLC) cell lines produce immunosuppressive factors and, if they do, to characterize the factors. The supernatants of SCLC cell lines, H69 and N857, inhibited not only the blastogenic response of human peripheral blood lymphocytes (PBL) to phytohemagglutinin or concanavalin A, but also the cytotoxic activity of lymphokine-activated killer cells. Neither was inhibited by supernatants from non-SCLC cell lines PC9, QG56, and A549. The immunosuppressive activity of H69 supernatant was stable upon heating to 56 degrees C for 60 min, but labile when heated to 70 degrees C for 10 min. The activity was abolished after dialysis at pH 2.0 or pH 11.0, but not at pH 4.5 or pH 9.0. Digestion with trypsin or proteinase eliminated the immunosuppressive activity, whereas treatment with neuraminidase, mixed glycosidase, DNase or RNase had no effect, suggesting that the immunosuppressive activity in H69 supernatant is due to a protein factor. This H69-derived immunosuppressive factor was isolated by ion exchange chromatography using a gradient of 0.04 to 0.08 M NaCl solution. Gel filtration and sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed the factor to have molecular weights of 98 kD and 102 kD, respectively. These results suggest that SCLC cells produce a potent immunosuppressive factor which may account for the immune deficiency in SCLC patients.

摘要

本研究旨在确定小细胞肺癌(SCLC)细胞系是否产生免疫抑制因子,若产生,则对这些因子进行特性描述。SCLC细胞系H69和N857的上清液不仅抑制人外周血淋巴细胞(PBL)对植物血凝素或刀豆球蛋白A的增殖反应,还抑制淋巴因子激活的杀伤细胞的细胞毒活性。非SCLC细胞系PC9、QG56和A549的上清液均无此抑制作用。H69上清液的免疫抑制活性在56℃加热60分钟后稳定,但在70℃加热10分钟则不稳定。在pH 2.0或pH 11.0透析后活性消失,但在pH 4.5或pH 9.0透析后活性未受影响。用胰蛋白酶或蛋白酶消化可消除免疫抑制活性,而用神经氨酸酶、混合糖苷酶、DNA酶或RNA酶处理则无作用,提示H69上清液中的免疫抑制活性归因于一种蛋白质因子。通过使用0.04至0.08 M NaCl溶液梯度的离子交换色谱法分离出这种源自H69的免疫抑制因子。凝胶过滤和十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳显示该因子的分子量分别为98 kD和102 kD。这些结果表明,SCLC细胞产生一种强效免疫抑制因子,这可能是SCLC患者免疫缺陷的原因。

相似文献

1
Characterization and purification of an immunosuppressive factor produced by a small cell lung cancer cell line.
Jpn J Cancer Res. 1991 Mar;82(3):332-8. doi: 10.1111/j.1349-7006.1991.tb01850.x.
2
[The enhancement of cytolytic activity in lymphokine activated killer cells using bispecific F(ab')2].
Nihon Ika Daigaku Zasshi. 1991 Dec;58(6):663-72. doi: 10.1272/jnms1923.58.663.
6
Characterization of lung squamous cell carcinoma-derived T-cell suppressive factor.
Cancer. 1993 Oct 15;72(8):2347-57. doi: 10.1002/1097-0142(19931015)72:8<2347::aid-cncr2820720810>3.0.co;2-i.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验